Key statistics dashboard for Silo Pharma, Inc. (SILO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems.
Stock Data
| Price | $1.76 |
| Market Cap | $2M |
| Enterprise Value | -$1.3M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.36 |
| Price / Book | 0.44 |
| P/S | 40.49 |
| EV/EBITDA | 0.28 |
| EV/Sales | -23.87 |
| EV/FCF | 0.39 |
| P/FCF | -0.66 |
| Earnings Yield | -231.30% |
| FCF Yield | -168.16% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -474.31% |
| EBIT Margin | -8489.57% |
| EBITDA Margin | -8473.27% |
| Operating Margin | -8250.46% |
| Net Margin | -8269.53% |
| Return on Equity | -81.74% |
| Return on Assets | -75.13% |
| Return on Invested Capital | -91.31% |
| Return on Capital Employed | -91.31% |
Financial Health
| Current Ratio | 5.36 |
| Quick Ratio | 5.36 |
| Cash Ratio | 3.07 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 0.72 |
| Interest Coverage | -112.03 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -3.06 |
Per-Share Data
| Revenue per share | 0.05 |
| Book Value per share | 4.45 |
| Cash per share | 4.95 |
| FCF per share | -3.04 |
| Tangible Book Value per share | 4.26 |
| Dividend per share | 0.00 |
Related companies: BDRX · CANF · CMND · CNSP · GRI · INM · JAGX
Explore sector: Healthcare · Biotechnology
More sections of SILO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks